0001104659-19-073728.txt : 20200122 0001104659-19-073728.hdr.sgml : 20200122 20191218145811 ACCESSION NUMBER: 0001104659-19-073728 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20191218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Applied Therapeutics Inc. CENTRAL INDEX KEY: 0001697532 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-220-9319 MAIL ADDRESS: STREET 1: 545 5TH AVENUE, SUITE 1400 CITY: NEW YORK STATE: NY ZIP: 10017 CORRESP 1 filename1.htm

 

Applied Therapeutics, Inc.

545 5th Avenue, Suite 1400

New York, New York 10173

 

 

December 18, 2019

 

VIA EDGAR AND EMAIL

 

Securities and Exchange Commission
Division of Corporation Finance
100 F Street NE
Washington, D.C. 20549

Attn:       Ada D. Sarmento

 

Re:                             Applied Therapeutics, Inc.

Registration Statement on Form S-1 (File No. 333-235504)

Request for Acceleration of Effective Date

 

Ladies and Gentlemen:

 

We refer to the registration statement on Form S-1 (File No. 333- 235504) (the “Registration Statement”), of Applied Therapeutics, Inc. (the “Company”), relating to the registration of the Company’s common stock, par value $0.0001 per share.

 

In accordance with Rules 460 and 461 under the Securities Act of 1933, as amended, the Company hereby respectfully requests that the effectiveness of the Registration Statement be accelerated so that it may become effective at 3:00 P.M. (Eastern time) on Friday, December 20, 2019, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

 

Please call Andrea L. Nicolas of Skadden, Arps, Slate, Meagher & Flom LLP, at (212) 735-3416, to confirm the effectiveness of the Registration Statement.

 

 

 

Very truly yours,

 

 

 

 

 

Applied Therapeutics, Inc.

 

 

 

 

 

 

By:

/s/ Shoshana Shendelman

 

 

 

Name:

Shoshana Shendelman

 

 

 

Title:

President and Chief Executive Officer (Principal Executive Officer)